Builder Investment Group’s AbbVie ABBV Stock Holding History

Builder Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$537K	Hold	2,133	–	–	0.11%	73
2026 Q1	$464K	Hold	2,133	–	–	0.1%	76
2025 Q4	$487K	Hold	2,133	–	–	0.11%	72
2025 Q3	$494K	Hold	2,133	–	–	0.11%	70
2025 Q2	$396K	Sell	2,133 -200	-9%	-$37.2K	0.1%	77
2025 Q1	$489K	Hold	2,333	–	–	0.14%	67
2024 Q4	$415K	Hold	2,333	–	–	0.11%	70
2024 Q3	$461K	Hold	2,333	–	–	0.12%	70
2024 Q2	$400K	Hold	2,333	–	–	0.11%	72
2024 Q1	$425K	Buy	2,333 +100	+4%	+$17.2K	0.12%	69
2023 Q4	$346K	Hold	2,233	–	–	0.12%	75
2023 Q3	$333K	Hold	2,233	–	–	0.13%	74
2023 Q2	$301K	Hold	2,233	–	–	0.12%	75
2023 Q1	$356K	Hold	2,233	–	–	0.16%	69
2022 Q4	$361K	Buy	+2,233	New	+$342K	0.17%	63

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Builder Investment Group's ABBV Position: Q2 2026 in Review

Builder Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 2,133 shares worth $537K. The position accounts for 0.11% of the portfolio, ranked #73.

Builder Investment Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Builder Investment Group held 2,133 shares of AbbVie worth $537K as of Q2 2026.
Builder Investment Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.11% of Builder Investment Group's portfolio in Q2 2026, its #73 holding.
Builder Investment Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Builder Investment Group's 13F filing for Q2 2026, filed 17 Jul 2026.